» Articles » PMID: 32082152

Exploring the Therapeutic Composition and Mechanism of Jiang-Suan-Chu-Bi Recipe on Gouty Arthritis Using an Integrated Approach Based on Chemical Profile, Network Pharmacology and Experimental Support Using Molecular Cell Biology

Overview
Journal Front Pharmacol
Date 2020 Feb 22
PMID 32082152
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gouty arthritis is a common metabolic disease caused by long-term purine metabolic disorder and elevated serum uric acid. Jiang-Suan-Chu-Bi recipe (JSCBR), a traditional Chinese herbal formula prescribed according to utilization frequency and cluster analysis, has been clinically validated remedy for gouty arthritis. However, its therapeutic composition and mechanism remains unclear.

Methods: In the present study, a simple, rapid, and sensitive ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS)-based chemical profiling was firstly established for comprehensively identifying the major constituents in JSCBR. A phytochemistry-based network pharmacology analysis was further performed to explore the potential therapeutic targets and pathways involved in JSCBR bioactivity. Finally, THP-1 cell model was used to verify the prediction results of network pharmacology by western blot analysis.

Results: A total of 139 compounds containing phenolic acids, flavonoids, triterpenoid saponins, alkaloids, amino acids, fatty acids, anthraquinones, terpenes, coumarins, and other miscellaneous compounds were identified, respectively. 175 disease genes, 51 potential target nodes, 80 compounds, and 11 related pathways based on network pharmacology analysis were achieved. Among these pathways and genes, NOD-like receptor signaling pathway may play an important role in the curative effect of JSCBR on gouty arthritis by regulation of NRLP3/ASC/CASP1/IL1B. The results of cellular and molecular experiments showed that JSCBR can effectively reduce the protein expression of ASC, caspase-1, IL-1β, and NRLP3 in monosodium urate-induced THP-1 cells, which indicated that JSCBR mediated inflammation in gouty arthritis by inhibiting the activation of NOD-like receptor signaling pathway.

Conclusion: Thus, the integrated approaches adopted in the present study could contribute to simplifying the complex system and providing directions for further research of JSCBR.

Citing Articles

Deciphering the biophysical aspects of the interaction of 3,5,4'-trihydroxy-trans-stilbene with ribonuclease A: spectroscopic and computational studies.

Sahoo B, Velavalapalli V Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39607551 DOI: 10.1007/s00210-024-03664-w.


Study on the Underlying Mechanism of Yinhua Gout Granules in the Treatment of Gouty Arthritis by Integrating Transcriptomics and Network Pharmacology.

Fan Q, Zhai B, Zhang D, Zhang X, Cheng J, Guo D Drug Des Devel Ther. 2024; 18:3089-3112.

PMID: 39050804 PMC: 11268870. DOI: 10.2147/DDDT.S475442.


Comparative study of trimming and resection of diseased finger superficial flexor tendons in gouty carpal tunnel syndrome.

Liu J, Gu F, Liu Q, Chen W, Ying Q, Xu Y BMC Musculoskelet Disord. 2023; 24(1):935.

PMID: 38042803 PMC: 10693067. DOI: 10.1186/s12891-023-07050-0.


Kaempferol Attenuates Gouty Arthritis by Regulating the Balance of Th17/Treg Cells and Secretion of IL-17.

Li N, Chen S, Deng W, Gong Z, Guo Y, Zeng S Inflammation. 2023; 46(5):1901-1916.

PMID: 37311931 DOI: 10.1007/s10753-023-01849-8.


Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments.

Zeng L, Lin Z, Kang P, Zhang M, Tang H, Li M Evid Based Complement Alternat Med. 2022; 2022:2322417.

PMID: 36193152 PMC: 9526673. DOI: 10.1155/2022/2322417.


References
1.
Li H, Ou G, He Y, Ren L, Yang X, Zeng M . Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity. Int Immunopharmacol. 2018; 67:62-68. DOI: 10.1016/j.intimp.2018.12.004. View

2.
Wilson L, Saseen J . Gouty Arthritis: A Review of Acute Management and Prevention. Pharmacotherapy. 2016; 36(8):906-22. DOI: 10.1002/phar.1788. View

3.
McCormack W, Parker A, ONeill L . Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Res Ther. 2009; 11(5):243. PMC: 2787278. DOI: 10.1186/ar2729. View

4.
Xu S, Qi X, Liu Y, Liu Y, Lv X, Sun J . UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma. Molecules. 2018; 23(12). PMC: 6320938. DOI: 10.3390/molecules23123234. View

5.
Liang J, Xu F, Zhang Y, Huang S, Zang X, Zhao X . The profiling and identification of the absorbed constituents and metabolites of Paeoniae Radix Rubra decoction in rat plasma and urine by the HPLC-DAD-ESI-IT-TOF-MS(n) technique: a novel strategy for the systematic screening and identification of.... J Pharm Biomed Anal. 2013; 83:108-21. DOI: 10.1016/j.jpba.2013.04.029. View